| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 | Sep'17 |
|---|---|---|---|---|---|---|---|---|---|
Revenues | |||||||||
Total revenues | |||||||||
558 | 959 | 0 | 0 | 0 | - | - | - | - | - |
Cost of product sales | |||||||||
0 | - | - | - | - | - | - | - | - | - |
Gross (loss) profit | |||||||||
0 | - | - | - | 0 | - | - | - | - | - |
Operating expenses: | |||||||||
Research and development | |||||||||
11,358 | 11,555 | 12,424 | 10,550 | 10,818 | 5,627 | 6,089 | 0 | 0 | 0 |
General and administrative | |||||||||
8,573 | 7,552 | 6,307 | 5,513 | 4,593 | 4,694 | 4,716 | 0 | 0 | 0 |
Total operating expenses | |||||||||
19,931 | 19,107 | 18,731 | 16,063 | 15,411 | 10,321 | 10,805 | 0 | 0 | 0 |
Loss from operations | |||||||||
-19,928 | -18,601 | -18,231 | -15,563 | -14,911 | -10,321 | -10,805 | 0 | 0 | 0 |
Other (expense) income: | |||||||||
Interest and other (expense) income, net | |||||||||
0 | - | - | - | 0 | - | - | - | - | - |
Interest and other income, net | |||||||||
- | - | 403 | 351 | - | 164 | 91 | 0 | 0 | 0 |
Change in fair value of warrant liability | |||||||||
- | - | - | - | - | 2,583 | 1,098 | 0 | 0 | 0 |
Loss before income tax expense | |||||||||
-19,959 | -18,320 | -19,354 | -17,299 | -17,132 | -12,740 | -11,812 | 0 | 0 | 0 |
Income tax expense | |||||||||
- | - | - | - | - | - | - | - | - | 0 |
Net loss | |||||||||
-19,959 | -18,320 | -19,354 | -17,299 | -17,132 | -12,740 | -11,812 | 0 | 0 | 0 |
Accrued dividends on redeemable convertible preferred stock | |||||||||
- | - | - | - | - | 1,048 | 1,203 | 0 | 0 | 0 |
Deemed dividends for accretion of redeemable convertible preferred stock issuance costs | |||||||||
- | - | - | - | - | 1,694 | 1,645 | 0 | 0 | 0 |
Net loss attributable to common stockholders | |||||||||
- | - | -41,686 | -40,360 | - | -37,229 | -14,660 | 0 | 0 | 0 |
Net loss per share, basic and diluted | |||||||||
-0.50 | -0.15 | -0.28 | -0.18 | -0.42 | -3.31 | -0.65 | -0.79 | -1.05 | -1.00 |
Weighted average number of common shares outstanding, basic and diluted | |||||||||
18,143 | 17,931 | 17,878 | 17,733 | 17,502 | 11,720 | 5,615 | 4,786 | 3,551 | 3,500 |
Product Sales [Member] | |||||||||
Total revenues | |||||||||
0 | - | - | - | - | - | - | - | - | - |
Licensing Revenue [Member] | |||||||||
Total revenues | |||||||||
- | - | - | - | 0 | - | - | - | - | - |